Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP 31 3-1 Month Momentum % is -16.34% as of Aug. 24, 2026. GuruFocus rates WAR:TMP with a GF Score™ of 31/100 and a GF Value™ of zł0.80 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Telemedycyna Polska ranks worse than 83.18% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-24), Telemedycyna Polska's 3-1 Month Momentum % is -16.34%.
The industry rank for Telemedycyna Polska's 3-1 Month Momentum % or its related term are showing as below:
WAR:TMP's 3-1 Month Momentum % is ranked worse than 83.18% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: -1.36
vs WAR:TMP: -16.34
Telemedycyna Polska (WAR:TMP) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Telemedycyna Polska 3-1 Month Momentum % Related Terms
WAR:TMP vs VEEV, BTSG, HQY: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, Telemedycyna Polska's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's 3-1 Month Momentum % falls into.
Telemedycyna Polska (WAR:TMP) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telemedycyna Polska (WAR:TMP) has a 3-1 Month Momentum % of -16.34% as of Aug. 24, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Telemedycyna Polska and its competitors. According to the industry distribution chart, Telemedycyna Polska ranks #559 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is Telemedycyna Polska's 3-1 Month Momentum % too high?
Telemedycyna Polska's current 3-1 Month Momentum % is -16.34%. Based on the distribution chart, Telemedycyna Polska ranks #559 out of 672 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #559 out of 672 companies for 3-1 Month Momentum %. This places Telemedycyna Polska in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Telemedycyna Polska and its competitors. Telemedycyna Polska's current 3-1 Month Momentum % is -16.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.80, compared to a current price of zł0.61 — trading 23.8% below its estimated fair value. The current 3-1 Month Momentum % is -16.34%. Telemedycyna Polska's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current 3-1 Month Momentum % is -16.34% as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.61 is trading 23.8% below its estimated GF Value™ of zł0.80.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
3-1 Month Momentum %: -16.34%
GF Value™: zł0.80 vs. price of zł0.61 (23.8% below fair value)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
31GF Score
Get the complete analysis for WAR:TMP
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
